Previous Close | 508.72 |
1-Year Change | 11.63% |
6-Months Change | -1.94% |
3-Months Change | -12.31% |
Moving Avg (50d) | 521.51 |
Moving Avg (200d) | 538.49 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 68.2B |
Beta (3-Years) | 0.29 |
Revenue Growth (ttm) | 7.01% |
Net Profit Margin (ttm) | 1.2% |
Return On Assets (ttm) | 5.28% |
EPS (ttm) | 25.33 |
PE Ratio (ttm) | 20.08 |
Dividend Yield | 0.44% |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Distributors |
Country: | United States |
McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 51,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United... Wikipedia